baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Knock-Out AMGN/ DE000MJ8YB93 /

1/24/2025 9:57:22 PM	Chg.-0.13	Bid10:00:39 PM	Ask10:00:39 PM	Underlying	Strike price	Expiration date	Option type
2.17EUR	-5.65%	- Bid Size: -	- Ask Size: -	Amgen Inc	252.3981 USD	12/31/2078	Call

TeleTrader 12/2/2024 US closes mostly higher on business sector news

TeleTrader 11/26/2024 Dow extends losses, drops by 300 points

TeleTrader 11/26/2024 Amgen plunges 11%, hits lowest level in a year

TeleTrader 11/26/2024 US opens mostly higher ahead of Fed's minutes

TeleTrader 11/12/2024 Wall Street closes lower as markets brace for CPI data

TeleTrader 10/30/2024 Amgen reports revenue of $8.5B in Q3, up 23%

TeleTrader 9/25/2024 Dow falls 290 pts at close as S&P 500 slips from record highs

GlobeNewswire 8/29/2024 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...

GlobeNewswire 8/28/2024 Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...

GlobeNewswire 8/26/2024 Molecular Partners Reports H1 2024 Corporate Highlights and Financials

GlobeNewswire 8/26/2024 Eliem Therapeutics Announces Additions to its Leadership Team

GlobeNewswire 8/15/2024 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...

GlobeNewswire 8/12/2024 TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 8/8/2024 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/8/2024 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

TeleTrader 8/7/2024 US closes lower with earnings in focus

TeleTrader 8/7/2024 US turns red, Dow loses more than 200 pts

GlobeNewswire 8/7/2024 89bio Appoints Francis Sarena as Chief Operating Officer

TeleTrader 8/6/2024 Amgen books revenue of $8.4B in Q2, up 20%

TeleTrader 8/6/2024 US extends premarket gains, Dow surges 250 pts

GlobeNewswire 8/5/2024 Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors

TeleTrader 8/1/2024 Dow jumps 250 pts as Meta surges more than 10%

GlobeNewswire 8/1/2024 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire 7/22/2024 Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 202...

GlobeNewswire 7/9/2024 ImCheck Appoints Stephan Braun as Chief Medical Officer

Morgan Stanley Knock-Out AMGN/ DE000MJ8YB93 /

If you wish to receive reply to your feedback, please provide your email address.